Also inside: New analyst coverage of two cannabis companies. One’s a leader in extraction with 100%+ upside, the other a best-in-class multi-state operator. Plus: Three stocks that could keep going higher.

Also inside: Top U.S. hemp-based CBD seller an established leader at the right time. Plus: Gold company could be acquisition target with projected return of 73%.

Also inside: New analyst coverage of cobalt and gold plays with projected returns of nearly 80% and 130%. Plus: This software stock has broken out after building a base for four years.

Also inside: New coverage of a U.S. marijuana player that has 109% upside. Plus: Four stock ideas for the new four-year market cycle.

Also inside: New coverage of a multi-faceted U.S. cannabis company with 50% upside. Plus: Three Canadian top picks offering growth and value.

Inside: 12 hand-selected stock picks from the likes of Fabrice Taylor, Ryan Irvine, Peter Hodson, Roger Dent and more. Plus: Dwight Galusha’s favorite chart set up for this year.

Also inside: New coverage of a “high conviction” Canadian health care technology company. Plus: Our best and worst ideas of 2018.

Also inside: Relax, take the long view, and get off your phone. Plus: This gas purification company has a record backlog and a projected return of nearly 130%.